Skip to main content

Table 7 Relationship between low HRQoL scores (PCS ≤50 or MCS ≤50) and occupational activity, tobacco use and being overweight during the survey

From: Sustained degradation of quality of life in a subgroup of lymphoma survivors: a two-year prospective survey

a Low Physical HRQoL scores (PCS < 50)

 

favorable group (PCS scores > 50 at M24)

n = 164

unfavorable group (PCS scores ≤ 50 at M24)

n = 34

P value

 Patients with occupational activity (110 employed at diagnosis)

number of patients who met the criteria/ total number of patients

number of patients who met the criteria/ total number of patients

 

  M0

44/164 (26.8%)

6/34 (17.6%)

n.s.

  M12

63/164 (38.4%)

6/34 (17.6%)

p < 0.05

  M24

71/164 (43.3%)

6/34 (17.6%)

p < 0.01

 Tobacco use

number of patients who met the criteria/total number of patients

number of patients who met the criteria/ total number of patients

 

 At diagnosis

33/164 (20.1%)

14/34 (41.2%)

p < 0.05

  M0

9/164 (5.5%)

5/34 (14.7%)

n.s.

  M12

9/164 (5.5%)

5/34 (14.7%)

n.s.

  M24

9/164 (5.5%)

5/34 (14.7%)

n.s.

 BMI > 30

number of patients who met the criteria/ total number of patients

number of patients who met the criteria/ total number of patients

 

  M0

18/164 (11.0%)

7/34 (20.6%)

n.s

  M12

19/164 (11.6%)

6/34 (17.6%)

n.s

  M24

24/164 (14.6%)

7/34 (20.6%)

n.s

b Low Mental HRQoL scores (MCS < 50)

 

favorable group (MCS scores > 50 at M24)

n = 165

unfavorable group (MCS scores ≤ 50 at M24)

n = 33

P value

 Patients with occupational activity (110 employed at diagnosis)

number of patients who met the criteria/ total number of patients

number of patients who met the criteria/ total number of patients

 

  M0

44/165 (26.7%)

6/33 (18.2%)

n.s.

  M12

63/165 (38.2%)

6/33 (18.2%)

p < 0.05

  M24

71/165 (43.0%)

6/33 (18.2%)

p < 0.05

 Tobacco use

  Diagnosis

33/165 (20.0%)

14/33 (42.4%)

p < 0.05

  M0

9/165 (5.5%)

5/33 (15.2%)

n.s.

  M12

9/165 (5.5%)

5/33 (15.2%)

n.s.

  M24

9/165 (5.5%)

5/33 (15.2%)

n.s.

 BMI > 30

  M0

18/165 (10.9%)

7/33 (21.2%)

n.s.

  M12

19/165 (11.5%)

6/33 (18.2%)

n.s.

  M24

24/165 (14.5%)

7/33 (21.2%)

n.s.